🇺🇸 FDA
Patent

US 11554140

Nucleic acid, chimeric antigen receptor expression plasmid, chimeric antigen receptor expressing cell, use thereof, and pharmaceutical composition for treating cancer

granted A61KA61K2039/505A61K2239/38

Quick answer

US patent 11554140 (Nucleic acid, chimeric antigen receptor expression plasmid, chimeric antigen receptor expressing cell, use thereof, and pharmaceutical composition for treating cancer) held by China Medical University Hospital expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
China Medical University Hospital
Grant date
Tue Jan 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/505, A61K2239/38, A61K2239/47, A61K2239/49